pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
RISING · news · pharmadog
← back to RISING
News mentioning RISING
268
stories
15d
As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university
stat
15d
New study examines GLP-1 impact on interactions with criminal justice system, employment, housing stability
stat
15d
Opinion: We think a baby’s gut microbiome could be key to lifelong brain health
stat
15d
Jazz CEO calls on industry to help rebuild momentum for leadership diversity
biospace
16d
STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more
stat
16d
Analysts eye RevMed’s pancreatic cancer launch, Merck’s data blitz for Q3 earnings
biospace
17d
Successful CDMO partnerships hinge on honest—and sometimes critical—support
biospace
20d
STAT+: Pharma’s free lunches for doctors boost inappropriate prescribing, analysis finds
stat
20d
This week in charts: What’s driving biotech’s recent pullback?
biopharma dive
20d
STAT+: Up and down the ladder: The latest comings and goings
stat
20d
Hengrui has become the go-to source of China biopharma innovation. What’s its secret?
fiercebiotech
20d
Lilly-backed TRex rakes in $117M IPO, while hypertension biotech Retension reveals $45M listing
fiercebiotech
22d
STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
stat
22d
5 biggest venture capital raises of Q3 2026
biospace
23d
TRex Bio stomps toward $111M IPO, as Retension and Lycia also gear up to go public
fiercebiotech
24d
STAT+: Prices, prices, prices
stat
24d
Hospital and pharmaceutical prices are smothering America’s businesses
stat
24d
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
biospace
27d
STAT+: Up and down the ladder: The latest comings and goings
stat
27d
Opinion: I treated heat stroke at the NYC Marathon. Marathons need to prepare for a climate-changed world
stat
28d
Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEO
fiercebiotech
28d
US government launches AI-driven programs to overhaul clinical trials
biospace
28d
Opinion: I studied GLP-1 use in children. The results are reassuring
stat
28d
STAT+: Can a top Republican from a bygone political era fix pharma’s woes in Washington?
stat
29d
Rural MAHA followers say Trump hasn’t improved health of their communities, poll finds
stat
29d
Lilly raises diabetes weight-loss bar with amylin-Zepbound combo
fiercebiotech
29d
CDC measles death count still lags Pennsylvania’s
stat
29d
Roche, Zealand see phase 2 amylin weight loss peak at mid-dose, start pivotal program
fiercebiotech
Sep 29, 26
Researchers slow neurodegeneration in mice by barring T cells from the brain
stat
Sep 29, 26
Opinion: Child health is the national security crisis we keep ignoring
stat
← prev
page 2 of 9
next →
